The DNA methylation landscape of advanced prostate cancer

Journal: Nature Genetics

Published: 2020-07-13

DOI: 10.1038/s41588-020-0648-8

Affiliations: 54

Authors: 69

Go to article
Institutions Share
UCSF Medical Center, United States of America (USA) 0.30
University of California, San Francisco (UCSF), United States of America (USA) 0.15
Michigan Medicine, U-M, United States of America (USA) 0.07
UCLA Health, United States of America (USA) 0.06
Illumina, Inc., United States of America (USA) 0.06
Vancouver Prostate Centre (VPC), Canada 0.05
Oregon Health and Science University (OHSU), United States of America (USA) 0.04
Washington University in St. Louis (WUSTL), United States of America (USA) 0.04
University of Minnesota (UMN), United States of America (USA) 0.03
Princess Margaret Cancer Centre, U of T, Canada 0.02
UC Davis Medical Center (UCDMC), United States of America (USA) 0.02
Ontario Institute for Cancer Research (OICR), Canada 0.02
University of Wisconsin-Madison (UW-Madison), United States of America (USA) 0.01
Duke University Health System, United States of America (USA) 0.01
Thomas Jefferson University (TJU), United States of America (USA) 0.01
Health Sciences, Pitt, United States of America (USA) 0.01
University of Pennsylvania (Penn), United States of America (USA) 0.01
University of Toronto (U of T), Canada 0.01
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.01
The University of Melbourne (UniMelb), Australia 0.01
UC Davis Health, United States of America (USA) 0.01
Netherlands Cancer Institute (NKI), Netherlands 0.01
Oncode Institute, Netherlands 0.01
BC Cancer Agency (BCCA), PHSA, Canada 0.01
Yale University, United States of America (USA) 0
VA Greater Los Angeles Healthcare System, United States of America (USA) 0

Return